Product Portfolio & DemandCyanotech's core products (Astaxanthin, Spirulina) address enduring consumer demand for natural, premium supplements. Specialized cultivation and high-quality sustainable production support repeat purchases, brand differentiation, and supplier credibility that sustain revenue resilience over quarters.

Gross Margin LevelA ~29.7% gross margin indicates product-level economics that can absorb distribution and some SG&A while preserving unit profitability. With disciplined operating cost control and scale, this gross margin provides a structural foundation to recover operating profits and reinvest in growth.

Asset-backed Production CapacityThe firm's substantial asset base likely reflects owned cultivation and processing facilities. These capital assets enable quality control, supply reliability and scalability, creating durable barriers to entry and long-term operational advantages versus asset-light competitors.

Bears Say

Persistent UnprofitabilityA negative net margin of -12.13% shows the company fails to convert sales into profit. Sustained losses erode equity and limit internal funding for capex or marketing. Without structural margin improvements, Cyanotech will remain reliant on external capital, raising medium-term risk.

Elevated LeverageA debt-to-equity ratio of 1.49 indicates material leverage that increases fixed financial obligations. High debt servicing reduces strategic flexibility, amplifies sensitivity to interest rates or revenue shocks, and can force prioritization of deleveraging over growth or R&D investments.

Weak Cash GenerationNegative operating cash flow and a 23.45% decline in free cash flow signal operations don't self-fund capex or debt service. This persistent cash shortfall increases reliance on external financing, constrains strategic initiatives, and raises liquidity and refinancing risks over the next several quarters.

CYAND FAQ

What was Cyanotech’s price range in the past 12 months?

Cyanotech lowest stock price was $0.21 and its highest was $0.57 in the past 12 months.

What is Cyanotech’s market cap?

Cyanotech’s market cap is $2.51M.

When is Cyanotech’s upcoming earnings report date?

Cyanotech’s upcoming earnings report date is Jun 30, 2026 which is in 101 days.

How were Cyanotech’s earnings last quarter?

Cyanotech released its earnings results on Feb 03, 2026. The company reported -$0.031 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.031.

Is Cyanotech overvalued?

According to Wall Street analysts Cyanotech’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cyanotech pay dividends?

Cyanotech does not currently pay dividends.

What is Cyanotech’s EPS estimate?

Cyanotech’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cyanotech have?

Cyanotech has 7,392,243 shares outstanding.

What happened to Cyanotech’s price movement after its last earnings report?

Cyanotech reported an EPS of -$0.031 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.794%.

Which hedge fund is a major shareholder of Cyanotech?

Currently, no hedge funds are holding shares in CYAND

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cyanotech

Cyanotech Corporation (CYAN) is a biotechnology company based in Hawaii that specializes in the cultivation and processing of microalgae. Operating primarily in the nutritional supplements and specialty chemical sectors, Cyanotech produces high-quality products such as Astaxanthin, a powerful antioxidant derived from the microalgae Haematococcus pluvialis, and Spirulina, a nutrient-rich blue-green algae. The company's core offerings are focused on health and wellness, catering to consumers seeking natural dietary supplements and functional foods.